NEUROGENE
Neurogene is a developer of generic medicines intended to improve patient outcomes for neurological disorders.The company's offerings include advancing genetic medicines for many neurological disorders where no effective treatment options exist, providing patients and families affected by rare neurological disorders with gene therapy that improves quality of life.
NEUROGENE
Social Links:
Industry:
Biotechnology
Founded:
2018-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.neurogene.com
Total Employee:
11+
Status:
Active
Total Funding:
68.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Autobahn Therapeutics
Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.
Rainier Therapeutics
Rainier Therapeutics is a developer of cancer therapeutics technology intended to offer advanced targeted therapy for bladder cancer.
Tiburio Therapeutics
Tiburio Therapeutics is a developer of drug compounds intended to treat tumors and endocrine diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
EcoR1 Capital
EcoR1 Capital investment in Series A - Neurogene
Samsara BioCapital
Samsara BioCapital investment in Series A - Neurogene
Redmile Group
Redmile Group investment in Series A - Neurogene
Cormorant Asset Management
Cormorant Asset Management investment in Series A - Neurogene
Official Site Inspections
http://www.neurogene.com Semrush global rank: 3.58 M Semrush visits lastest month: 4.02 K
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
